Medical cannabis has been proposed as a treatment for so many ailments, it’s hard to keep track: chronic pain, nausea, insomnia, autism and epilepsy, among others.
Tel Aviv cannabis company Medivie Therapeutic wants to add another to the list, as an alternative to toothpaste.
A subsidiary of the company, Mustix, has filed a patent request for a gum-like dental product with cannabis as one of its main ingredients. (Mastik is Hebrew for “gum.”)
If the Medivie’s Mustix gum works as the company’s initial tests show, it can clean up to 98% of mouth bacteria, remove plaque and whiten teeth.
Toothpaste and mouthwash as we know it may become superfluous – all you’ll need to do is chew.
Mustix will begin clinical trials shortly in collaboration with the Hebrew University of Jerusalem. The trials are expected to conclude in April 2020.
The company, which is 85% owned by the publicly traded Medivie (MDVI.TA), says it is committed to funding development in exchange for an exclusive license, while the university will be entitled to royalties.
In 2017, Medivie inked a nearly €2 million deal with Amsterdam-based cannabis seeds producer Barney’s Farm to grow cannabis on a kibbutz in northern Israel. Barney’s also invested in Medivie at a valuation of more than $14 million.
Mustix is a bit of an odd choice for the brand; it’s also the name of one of Israel’s leading chewing-gum manufacturers. But the bigger question is, will Medivie’s upcoming product cause the munchies as some strains of cannabis do? After all, midnight snacks might counteract the benefits of the gum.